PetVivo Holdings, Inc. (PETV)
OTC Markets OTCQX
Price as at 30 Sept 2026, 23:21 UTC. Quotes are delayed.
Fundamentals
Valuation and ratings
PetVivo Holdings, Inc. trades at $0.80. We do not hold enough of the inputs to value this company with the confidence the estimate implies, so we publish no fair value for it rather than a number we would not defend.
About PetVivo Holdings, Inc.
PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States. The company's lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. It also provides therapeutic devices for veterinary and human clinical applications. The company is based in Edina, Minnesota.
Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.
Common questions
Where does SteadyShares get its PETV data?
Fundamentals for PETV come from company filings and exchange data, as listed on OTC Markets OTCQX; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 30 Sept 2026, 23:21 UTC and is delayed. Metrics we do not hold are left out of the page rather than estimated.
The full research page for PETV, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.